Reuters logo
BRIEF-Braeburn Pharmaceuticals' Probuphine implant receives J-code by Centers for Medicare & Medicaid Services
January 13, 2017 / 1:17 PM / 10 months ago

BRIEF-Braeburn Pharmaceuticals' Probuphine implant receives J-code by Centers for Medicare & Medicaid Services

Jan 13 (Reuters) - Titan Pharmaceuticals Inc

* Braeburn pharmaceuticals’ Probuphine implant receives j-code by Centers for Medicare & Medicaid Services

* Braeburn Pharmaceuticals says new J-code (J0570) became effective January 1, 2017

* Braeburn Pharmaceuticals Inc says Centers for Medicare & Medicaid Services has granted a healthcare common procedure coding system (HCPCS) code Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below